SCHEMBL3645596

SCHEMBL3645596

[CH2]c1ccc(Cc2ncc[nH]2)cc1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 10/20 0.67
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
ALOX15 P16050 1/20 0.40
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
GLA P06280 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
TERT O14746 1/20 0.37
ALDH1A1 P00352 1/20 0.35
FDPS P14324 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13372830 0.90 TAAR1 (0.80) TAAR1HTR1AADRA2AADRA2BADRA2C
SCHEMBL11295562 0.82 TAAR1 (0.69) TAAR1HTR1AADRA2AADRA2BADRA2C
SCHEMBL2870029 0.81 TAAR1 (0.67) TAAR1HTR1AADRA2AADRA2BADRA2C
SCHEMBL4033056 0.81 TAAR1 (0.67) TAAR1HTR1AADRA2AADRA2BADRA2C
SCHEMBL177767 0.81 TAAR1 (0.67) TAAR1HTR1AADRA2AADRA2BADRA2C
SCHEMBL8210853 0.81 TAAR1 (0.67) TAAR1HTR1AADRA2AADRA2BADRA2C
SCHEMBL6323409 0.81 TAAR1 (0.67) TAAR1HTR1AADRA2AADRA2BADRA2C
SCHEMBL11290384 0.81 TAAR1 (0.67) TAAR1HTR1AADRA2AADRA2BADRA2C
SCHEMBL7094005 0.80 TAAR1 (0.61) TAAR1HTR1AADRA2AADRA2BADRA2C
SCHEMBL6165760 0.80 TAAR1 (0.71) TAAR1HTR1AADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2173740-A1 HEME-OXYGENASE INHIBITORS AND USE OF THE SAME IN THE TREATMENT OF CANCER AND DISEASES OF THE CENTRAL NERVOUS SYSTEM Osta Biotechnologies (CA) 2010-04-14 EP claimed
WO-2008151437-A1 HEME-OXYGENASE INHIBITORS AND USE OF THE SAME IN THE TREATMENT OF CANCER AND DISEASES OF THE CENTRAL NERVOUS SYSTEM OSTA BIOTECHNOLOGIES (CA) 2008-12-18 WO claimed
EP-1537111-A1 HETEREOARYL NITRILE DERIVATIVES Novartis AG (CH) 2005-06-08 EP disclosed
WO-2004020441-A1 HETEREOARYL NITRILE DERIVATIVES NOVARTIS AG (CH) 2004-03-11 WO disclosed